This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment from a licensed prescriber. If you or someone you know is in immediate danger, call 911. For crisis support, call or text 988 to reach the Suicide and Crisis Lifeline, or contact the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7).
Suboxone and Subutex are both used to treat opioid use disorder, and both share the same active ingredient, buprenorphine. What separates them is a second ingredient, naloxone, that Suboxone contains and Subutex does not. That second ingredient shapes which one a prescriber may recommend for a given patient. If you are considering Medication-Assisted Treatment (MAT), or trying to make sense of a loved one’s prescription, the difference between Suboxone and Subutex is worth knowing.
How Buprenorphine Works in Both Medications
Before comparing the two, it helps to understand what they share. Buprenorphine is a partial opioid agonist. It attaches to the same mu-opioid receptors in the brain as heroin, fentanyl, and oxycodone, but activates them only partially. When taken as prescribed, that partial activation can ease opioid cravings and withdrawal symptoms while producing less euphoria than a full opioid agonist.
Buprenorphine also has what pharmacologists call a ceiling effect. Past a certain dose, taking more does not keep raising its opioid effects, including its effect on breathing. That ceiling is a large part of why buprenorphine carries a lower risk of overdose than full opioid agonists. Since both Suboxone and Subutex contain buprenorphine, they share this ceiling effect.
None of this makes buprenorphine risk-free. It is still an opioid and a Schedule III controlled substance that can be misused, and regular use leads to physical dependence, so stopping suddenly can bring on withdrawal. Its protection against overdose also narrows when it is combined with alcohol or benzodiazepines, a combination the FDA warns can cause respiratory depression, coma, and death. That is why buprenorphine is prescribed and monitored as part of a full treatment plan, not taken on its own.
The Key Difference: What Naloxone Does in Suboxone
Suboxone combines buprenorphine with naloxone, an opioid antagonist added as a built-in safeguard against misuse.
When Suboxone is taken as directed, dissolved under the tongue (sublingual) or against the inside of the cheek (buccal), the naloxone is barely absorbed and has little effect, while the buprenorphine works as intended. The naloxone is there to discourage tampering with the medicine.
This built-in safeguard is a major reason the combination is the preferred form of buprenorphine for most patients, with the buprenorphine-only form (Subutex) reserved mainly for specific situations such as pregnancy or a naloxone allergy.
Subutex: The Buprenorphine-Only Formulation
Subutex was the original brand name for a buprenorphine-only tablet, the same core medication found in Suboxone but without the added naloxone. The brand-name version is no longer marketed in the United States, though the medication itself is still available as a generic buprenorphine-only tablet.
That buprenorphine-only form is reserved for specific situations where the added naloxone is unnecessary or not advisable.
When the Buprenorphine-Only Form Is Prescribed
- Pregnancy. The buprenorphine-only form has traditionally been chosen during pregnancy to avoid exposing the developing baby to naloxone. More recent research has found comparable outcomes with the combination product, and both are now considered reasonable options, so the choice is made with the treating clinician. A patient already stabilized on either form during pregnancy should not change or stop the medication on their own; that decision belongs with their prescriber.
- A known naloxone allergy. A patient with a documented allergic reaction to naloxone may be prescribed the buprenorphine-only form instead.
Outside of these situations, the combination product is the preferred choice for most patients.
| Feature | Suboxone | Subutex / buprenorphine-only |
|---|---|---|
| Active ingredients | Buprenorphine and naloxone | Buprenorphine only |
| Typically prescribed for | Most patients | Specific situations, such as pregnancy or a documented naloxone allergy |
| Use in pregnancy | A reasonable option, decided with the prescriber | Traditionally preferred, and still a reasonable option |
| Formulation | Film or tablet | Tablet |
| Availability | Widely available | Available as a generic; less commonly used |
| FDA approval | 2002 | 2002 (brand later discontinued; generics still available) |
The naloxone in the combination product is a built-in safeguard against misuse. Taken as directed, it is barely absorbed and has little effect of its own; the buprenorphine is what treats opioid use disorder. In pregnancy, both forms can be reasonable options, and any decision to start, stop, or switch medication should be made with a prescriber.
Is Suboxone or Subutex More Effective?
No, neither form is more effective than the other. Both work through the same active ingredient, buprenorphine, which is what treats opioid use disorder. NIDA describes buprenorphine as a safe and effective medication for opioid use disorder, and the naloxone in the combination product does not add to that effect.
The naloxone is there for a different reason. It is added to deter misuse, and when the medicine is taken as directed only a negligible amount of it is absorbed. That is why the combination product is the usual choice for most patients who are not pregnant and have no reason to avoid naloxone: not because it works better, but because of the built-in safeguard the naloxone provides.
What Happens During Induction: Why Timing Matters
Starting buprenorphine, in either form, has to be timed carefully, and it is one of the clearest reasons the medication is started under medical supervision. If it is taken too soon, before enough of the other opioids have left the body, it can bring on precipitated withdrawal, a sudden and more intense withdrawal than the body would produce on its own. This happens because buprenorphine binds more tightly to the same receptors and displaces the opioids already on them.
To avoid it, clinicians wait until a person is clearly in withdrawal before giving the first dose, and they use standard tools such as the Clinical Opiate Withdrawal Scale (COWS) to judge that timing. Fentanyl makes this harder. It can build up in the body’s fatty tissue and clear slowly, which raises the risk of precipitated withdrawal and can mean a longer wait before buprenorphine is started.
At Freeman Recovery Center, buprenorphine is started within a medically supervised medication-assisted treatment program, so the timing and the risks are handled by the clinical team rather than left to the patient.
Why Buprenorphine-Based Treatment Works Best Inside a Structured Program
Suboxone and the buprenorphine-only form are both tools, not a whole treatment plan on their own. Buprenorphine treats the physical side of opioid dependence, easing cravings and withdrawal. What it does not do by itself is address the things that often sit underneath substance use, such as trauma, a co-occurring mental health condition, or long-standing behavioral patterns. The CDC describes combining medication with behavioral therapy as an evidence-based approach, and notes that counseling and other support may add benefit for some people.
At Freeman Recovery Center, MAT is delivered alongside individual therapy, group sessions, and dual diagnosis care for people also living with conditions like depression, anxiety, or PTSD. Treating the dependence and the mental health condition together, rather than one at a time, is what a structured program is built to do.
